Evidence map›Paper›PMID 34071680›Full record

ReviewInternational journal of molecular sciences2021

Renal Handling of Albumin-From Early Findings to Current Concepts.

Jakub Gburek, Bogusława Konopska, Krzysztof Gołąb

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Veterinary world · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Prolonged Direct Hyperbilirubinemia Following Acute Hepatitis: When Not to Worry?Journal of clinical and translational hepatology · 2024
    Article
  15. Article
  16. Article
  17. To treat or not to treat: CUBN-associated persistent proteinuria.Kidney research and clinical practice · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jakub GburekDepartment of Pharmaceutical Biochemistry, Wroclaw Medical University, Borowska 211A, 50-556 Wrocław, Poland.
Bogusława KonopskaDepartment of Pharmaceutical Biochemistry, Wroclaw Medical University, Borowska 211A, 50-556 Wrocław, Poland.ORCID 0000-0003-1388-1989
Krzysztof GołąbDepartment of Pharmaceutical Biochemistry, Wroclaw Medical University, Borowska 211A, 50-556 Wrocław, Poland.ORCID 0000-0002-9257-1497
Wroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Albumin is the main protein of blood plasma, lymph, cerebrospinal and interstitial fluid. The protein participates in a variety of important biological functions, such as maintenance of proper colloidal osmotic pressure, transport of important metabolites and antioxidant action. Synthesis of albumin takes place mainly in the liver, and its catabolism occurs mostly in vascular endothelium of muscle, skin and liver, as well as in the kidney tubular epithelium. Long-lasting investigation in this area has delineated the principal route of its catabolism involving glomerular filtration, tubular endocytic uptake via the multiligand scavenger receptor tandem-megalin and cubilin-amnionless complex, as well as lysosomal degradation to amino acids. However, the research of the last few decades indicates that also additional mechanisms may operate in this process to some extent. Direct uptake of albumin in glomerular podocytes via receptor for crystallizable region of immunoglobulins (neonatal FC receptor) was demonstrated. Additionally, luminal recycling of short peptides into the bloodstream and/or back into tubular lumen or transcytosis of whole molecules was suggested. The article discusses the molecular aspects of these processes and presents the major findings and controversies arising in the light of the research concerning the last decade. Their better characterization is essential for further research into pathophysiology of proteinuric renal failure and development of effective therapeutic strategies.

Indexed as

AlbuminsAnimalsEndocytosisEndothelium, VascularHistocompatibility Antigens Class IHumansKidneyKidney Tubules, ProximalLiverPodocytesReceptors, FcAlbuminsFc receptor, neonatalHistocompatibility Antigens Class IReceptors, Fcalbumincubilinmegalinproteinuriarenal catabolism of proteinsrenal proximal tubule

Identifiers

PMID34071680
PMCPMC8199105
OpenAlexW3164829605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.